Advertisement Novartis to acquire additional stake in its Indian subsidiary - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Novartis to acquire additional stake in its Indian subsidiary

Novartis has announced a tender offer to acquire an additional stake of up to approximately 39% in its majority-owned Indian subsidiary, Novartis India, from public shareholders at a price of INR351 per share.

Successful completion of this offer would raise the stake of Novartis in its Indian subsidiary to nearly 90% from the current level of 50.9%. The offer represents a total value of up to INR4.4 billion.

The offer for these shares is expected to open in May 2009 and is subject to regulatory approvals.

The offer by Novartis, a Group subsidiary, has been made at a premium of 27% to the closing share price of INR275.6 of Novartis India on March 24, 2008 which was the last trading day before this announcement. It also represents a premium of 35% over Novartis India’s average share price during February 2009.